Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
1.030
+0.041 (4.17%)
Aug 26, 2025, 4:00 PM - Market closed

Oncolytics Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
103711009776103
Upgrade
Market Cap Growth
-10.02%-28.89%3.47%27.24%-25.88%-17.85%
Upgrade
Enterprise Value
935870733982
Upgrade
Last Close Price
1.030.911.351.631.392.38
Upgrade
PB Ratio
22.4717.134.804.952.675.29
Upgrade
P/TBV Ratio
23.1517.134.804.952.675.29
Upgrade
Debt / Equity Ratio
0.150.180.020.010.020.02
Upgrade
Quick Ratio
2.242.398.248.1515.3711.56
Upgrade
Current Ratio
2.882.829.019.0516.6912.45
Upgrade
Return on Equity (ROE)
-249.28%-189.05%-102.66%-79.34%-86.45%-182.63%
Upgrade
Return on Assets (ROA)
-74.56%-74.11%-55.46%-40.44%-40.88%-58.93%
Upgrade
Return on Capital (ROIC)
-146.95%-124.82%-76.99%-52.89%-52.97%-124.54%
Upgrade
Earnings Yield
-21.57%-30.93%-20.98%-18.95%-27.32%-17.20%
Upgrade
FCF Yield
-17.26%-26.54%-21.51%-17.86%-23.59%-16.89%
Upgrade
Buyback Yield / Dilution
-11.95%-13.10%-16.53%-8.44%-32.66%-82.22%
Upgrade
Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q